John Harold Leaman is of Onconova Therapeutics, Inc.. Currently has a direct ownership of 4,058 shares of ONTX, which is worth approximately $2,394. The most recent transaction as insider was on Dec 12, 2025, when has been sold 4,058 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.06K
n/a 3M change
n/a 12M change
Total Value Held $2,394

John Harold Leaman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2025
BUY
Grant, award, or other acquisition
-
4,058 Added 50.0%
4,058 Common Stock

Also insider at

IMPL
IMPEL PHARMACEUTICALS INC Healthcare
JHL

John Harold Leaman

Seattle, WA

Track Institutional and Insider Activities on ONTX

Follow Onconova Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONTX shares.

Notify only if

Insider Trading

Get notified when an Onconova Therapeutics, Inc. insider buys or sells ONTX shares.

Notify only if

News

Receive news related to Onconova Therapeutics, Inc.

Track Activities on ONTX